PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform

cited authors

  • Liu, S. H.; Rao, D. D.; Nemunaitis, J.; Senzer, N.; Zhou, G.; Dawson, D.; Gingras, M. C.; Wang, Z.; Gibbs, R.; Norman, M.; Templeton, N. S.; Demayo, F. J.; O'Malley, B.; Sanchez, R.; Fisher, W. E.; Brunicardi, F. C.

authors

publication date

  • 2012

published in

start page

  • e40452

volume

  • 7